Clinical trial
A Multicenter Retrospective Study Identifying DNA 5mC Predictors for LUAD Prognosis
NCT06477211 is registered in ClinicalTrials.gov with Nanjing University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multicenter Retrospective Study Identifying DNA 5mC Predictors for LUAD Prognosis
- Lead sponsor
- Nanjing University
- Phase
- Observational
- Overall status
- Completed
- Start date
- February 1, 2024
- Completion date
- January 20, 2025
- Enrollment
- 292 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
lung adenocarcinoma, prognostic cancer model, surgery